Epogen Market, By Indication (Anemia Due to Chronic Kidney Disease, Anemia Due to Zidovudine in Patients with HIV Infection, Anemia Due to Chemotherapy in Patients with Cancer, Reduction of Allogeneic Red Blood Cell Transfusions in Patients, Undergoing Elective, Noncardiac, and Nonvascular Surgery), By Strength (2,000 Units/mL, 3,000 Units/mL, 4,000 Units/mL, 10,000 Units/mL, 20,000 Units/mL, and 40,000 Units/mL), By Dosage Form (Injection (Single-dose vials and Multi-dose vials)), By Route of Administration (Intravenous and Subcutaneous), By End User (Hospitals, Dialysis Centers, Oncology Clinics & Cancer Treatment Centers, Specialty Pharmacies & Home Healthcare Providers, Long-Term Care Facilities & Nursing Homes, and Others (Research Institutes, etc.)), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
선택하다 귀사의 비즈니스 요구 사항에 맞는 라이센스 유형
US$ 2,200
이천이백 달러
단일 사용자 라이센스
( 전체 보고서 )
US$ 4,500
US$ 3,000
Three thousand dollars
자주 구매되는 상품
다중 사용자 라이센스
(전체 보고서)
US$ 7,000
US$ 5,000
Five thousand dollars
기업 사용자 라이센스
(전체 보고서)
US$ 10,000
US$ 6000
Six thousand dollars
Client Testimonials
Client Testimonials
우리의 고객